News

Filter

Three of Takeda's diabetes therapies get positive opinion from EMA unit

29-07-2013

Japan's largest drugmaker Takeda (TSE: 4502) has received a positive opinion from the European Medicines…

DiabetesEuropeIncresyncPharmaceuticalRegulationTakeda PharmaceuticalsVipdometVipidia

Back to top